Genetix Group makes fifth bid for Applied Imaging
This article was originally published in Clinica
Executive Summary
Genetix Group has raised its offer for Applied Imaging from $23.2m to $25.8m, as it continues to bid against an unnamed third party (see Clinica No 1231, p 14). The UK AIM-listed company has signed four previous merger agreements with San Jose, California-based AI, each of which have been trumped by the other bidder. Its first offer was $18.3m.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.